Rising prevalence of infectious diseases and increasing focus on production of therapeutic antibodies for treating cancer and other chronic diseases are key factors boosting global market growth
The global antibody production market size is expected to reach USD 33.52 Billion in 2028 and register a CAGR of 13.1%, according to the latest report by Reports and Data. Key factors such as rising investments in research and development activities and increasing demand for cost-effective therapeutic treatments are boosting global market revenue growth.
Antibodies are extensively used in diagnostics, research, and therapeutic purposes due to key features such as high specificity, binding affinity, and low toxicity. The global antibody production market is driven by key factors including patent cessation of monoclonal antibodies, gradual government acceptance for various targeted immunotherapy, and antibody therapeutics to treat several chronic diseases like cancer, and rheumatic arthritis. Rapid growth in the pharmaceutical and biotechnology sector, growing adoption of protein therapeutics, and availability of enhanced technology for antibody production are also fueling global market growth.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1404
The report puts an emphasis on the information regarding the key players with a special focus on their company profile, business overview, recent advancements, product catalog, and strategic business plans. It provides a comprehensive overview of the strategic alliances in the market under taken by the key players such as mergers and acquisitions, joint ventures, collaborations, partnerships, agreements, product launches, brand promotions, and corporate deals, among others.
Key companies operating in the market and profiled in the report include:
Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG, FiberCell Systems Inc GeneTex, Inc., Eli Lilly and Company, Pall Corporation, Merck KGaA, Eppendorf AG, Abcam PLC, and Sigma Aldrich Corporation
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1404
The Antibody Production market takes into account major geographical locations such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa to offer key insights into market growth, market size, market share, revenue growth, current and emerging trends, supply and demand ratio, import/export, consumer demand and behavior, and presence of key players in each region. The report offers an in-depth country wise analysis to impart better understanding of the market and its growth prospects.
Segments Covered in the report
Class Outlook (Revenue, USD Billion, 2020 - 2028)
- Monoclonal antibodies
- Polyclonal Antibodies
- Murine
- Chimeric
- Humanized
Process Outlook (Revenue, USD Billion, 2020 - 2028)
- Upstream Processing
- Bioreactors
- Large-scale bioreactors
- Single-use bioreactors
- Consumables
- Media
- Buffers and Reagents
- Downstream Processing
- Chromatography Systems
- Chromatography Resins
- Filtration
- Filtration Systems
- Filtration Consumables and Accessories
End-Use Outlook (Revenue, USD Billion, 2020 - 2028)
- Pharmaceutical Biotechnology Companies
- Diagnostic Laboratories
- Research Institutes
- Others
Key Regions Analyzed in the Report include:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/antibody-production-market
Furthermore, it consists information about individual segment of the Antibody Production market based on the types and application. The report also offers insights about the key segments expected to register significant revenue growth over the forecast period and primary trends influencing their growth. It also offers CAGR and market share values for each segment to provide clear understanding of demand and trend in the global market.
Key highlights in the report:
- The polyclonal antibodies segment is projected to account for significant revenue growth between 2021 and 2028. High demand for polyclonal antibodies is due to its quick production, comparatively easy purification, cost-effectiveness, and high chances of getting better antigen response by producing antibodies in various animals.
- Based on the process, the downstream process is expected to account for lucrative growth throughout the forecast period. High usage of chromatography systems for production of antibodies is an essential factor boosting segment revenue growth. The downstream process is commonly used owing to high accuracy and efficiency.
- Among the end-use segments, the research institutes segment is projected to account for rapid revenue growth during the forecast period owing to rising investments in RD activities, increasing research on genomics and proteomics, and increasing focus on identifying new biomarkers.
- North America accounted for largest revenue share in 2020 and is expected to maintain its dominant position throughout the forecast period. Presence of dominant pharmaceutical and biotechnology companies, technological advancements, availability of latest equipment, well-developed healthcare infrastructure and facilities, increasing investments in RD, and high focus on drug discovery are key factors fueling market growth in this region.
- Europe is expected to account for significant revenue growth over the forecast period owing to presence of leading key players, rising prevalence of contagious diseases, and ongoing research activities.
- The antibody production market in Asia Pacific is projected to register fastest revenue CAGR over the forecast period. Increasing incidence of various chronic diseases, improving healthcare infrastructure and other facilities, and increasing research and development activities are some factors supporting market revenue growth in Asia Pacific.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1404
Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.
Browse More Reports:
Infectious Disease Diagnostics Market @ https://www.reportsanddata.com/report-detail/infectious-disease-diagnostics-market
Wearable Robots Market @ https://www.reportsanddata.com/report-detail/wearable-robots-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
